Reaction Details |
| Report a problem with these data |
Target | Fibroblast growth factor receptor 3 |
---|
Ligand | BDBM161450 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Measurement of Inhibitory Effect on FGFR3 Kinase Activity |
---|
IC50 | 0.700±n/a nM |
---|
Citation | Ochiiwa, H; Hirai, H Antitumor drug for intermittent administration of FGFR inhibitor US Patent US10894048 Publication Date 1/19/2021 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Fibroblast growth factor receptor 3 |
---|
Name: | Fibroblast growth factor receptor 3 |
Synonyms: | CD_antigen: CD333 | FGFR-3 | FGFR3 | FGFR3_HUMAN | Fibroblast growth factor receptor | Fibroblast growth factor receptor 3 (FGFR3) | JTK4 |
Type: | Protein |
Mol. Mass.: | 87699.57 |
Organism: | Homo sapiens (Human) |
Description: | P22607 |
Residue: | 806 |
Sequence: | MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELS
CPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNASHEDSGAYSCRQRLTQRVLCH
FSVRVTDAPSSGDDEDGEDEAEDTGVDTGAPYWTRPERMDKKLLAVPAANTVRFRCPAAG
NPTPSISWLKNGREFRGEHRIGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQT
YTLDVLERSPHRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGP
DGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHHSAWLVVLPAE
EELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRSPPKKGLGSPTVHKISRFPLK
RQVSLESNASMSSNTPLVRIARLSSGEGPTLANVSELELPADPKWELSRARLTLGKPLGE
GCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIIN
LLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQ
VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKW
MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT
HDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSAPFEQYSPGGQDTPSS
SSSGDDSVFAHDLLPPAPPSSGGSRT
|
|
|
BDBM161450 |
---|
n/a |
---|
Name | BDBM161450 |
Synonyms: | US10124003, Ex. Compound 63 | US10835536, Ex. Comp 63 | US10894048, Ex Comp 62 | US9108973, 63 |
Type | Small organic molecule |
Emp. Form. | C27H30N6O4 |
Mol. Mass. | 502.5649 |
SMILES | COc1cc(OC)cc(c1)C#Cc1cn(C2CN(C2)C(=O)\C=C\CN2CC[C@@H](O)C2)c2ncnc(N)c12 |r| |
Structure |
|